详情页 - 河北医科大学第四医院机构库

当前位置：首页 > 详情页

Real-World Effectiveness of Osimertinib for Patients With Non-Small Cell Lung Cancer

7| 链接全文 |

文献详情

编号/登记号：

注册时间：

研究开始时间：

研究结束时间：

项目类型：

本院角色：

多中心研究：

招募状态：

研究疾病/适应症：

研究类型：

研究参与人：

研究单位： [1]Shanghai JMT-Bio Inc. [2]Beijing Cancer Hospital Beijing, China [3]Cancer Hospital Chinese Academy of Medical Sciences Beijing, China [4]Chinese People's Liberation Army General Hospital Beijing, China [5]Chongqing Cancer Hospital Chongqing, China [6]Southwest Hospital of Army Medical University Chongqing, China [7]Fujian Cancer Hospital Fuzhou, China [8]Sun Yat-sen University Cancer Center Guangzhou, China [9]The First Affiliated Hospital of Guangzhou Medical University Guangzhou, China [10]The First Affiliated Hospital of Sun Yat-Sen University Guangzhou, China [11]Anhui Cancer Hospital Hefei, China [12]Shandong Cancer Hospital Jinan, China [13]Nanjing Chest Hospital Nanjing, China [14]Fudan University Cancer Hospital Shanghai, China [15]Shanghai Chest Hospital Shanghai, China [16]Shanxi Provincial People's Hospital Shanxi, China [17]The Fourth Hospital of Hebei Medical University Shijia Zhuang, China [18]West China Hospital of Sichuan University Sichuan, China [19]Shanxi Cancer Hospital Taiyuan, China [20]Huazhong University of Science Tongji Hospital, Tongji Medical College Wuhan, China [21]Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology Wuhan, China [22]The First Affiliated Hospital of Xi'an Jiaotong University Xi'an, China [23]First Affiliated Hospital of Zhengzhou University Zhengzhou, China [24]Henan Cancer Hospital Zhengzhou, China [25]Affiliated Hospital of Hebei University Baoding, China

研究目的：

This study is a retrospective real-world study to evaluate the efficacy of Osimertinib for patients with advanced or metastatic EGFR 20exon insertion mutation (20ins) Non-Small Cell Lung Cancer.